<p>Vδ2<sup>+</sup>CD3<sup>+</sup> cell frequencies among expanded cells (<b>A</b>) and Vδ2<sup>+</sup>CD3<sup>+</sup> cell numbers generated from 1×10<sup>6</sup> PBMCs (<b>B</b>) were measured at 14 days after BrHPP (<b>▴</b>) or zoledronate (Zol) (<b>▪</b>) stimulation. The results from n = 60 patient PBMCs and n = 13 donor PBMCs are shown.</p
<p>(<b>A, B</b>) Healthy donor PBMCs were treated with different concentrations of EPs 7630 as indic...
<p><b>A</b>. PBMC from Endemic Normal (EN), Microfilaraemic (MF) and Chronic Pathology (CP) groups w...
We evaluated disseminated tumor cells (DTCs) and circulating tumor cells (CTCs) in patients with sta...
<p>Vδ2<sup>+</sup> T cell frequencies in expanded cells (Vδ2<sup>+</sup>CD3<sup>+</sup> staining) an...
<p><b>A, B</b>) Vδ2<sup>+</sup>CD3<sup>+</sup> cell fold increases in LR (n = 16) and R (n = 32) EOC...
<p>(A) PBMC proliferation stimulated by different parental somatic cells (SFs and UMCs). (B) Prolife...
Flow-cytometry analysis of healthy donor and patients PBMC following three days of PMA/ionomycin sti...
<p>Each value represents the mean ± SD of multiple experiments (each point being in triplicate). PBM...
<p>(A) CD100 expression on CD5+ and CD5- B cells from one representative, healthy donor before and a...
B cells were isolated and stimulated with CD40L/LPS/CpG for 2 days. Unstimulated (US) and stimulated...
<p>Bovine PBMCs were labeled with CFSE before stimulation with FTA alone, BVDV alone or BVDV plus FT...
<p>Venous blood samples from 4 healthy donors were stimulated with SEB for 24 hours either as whole ...
<p>Averaged “CD3ζ<sup>bright</sup>/CD3ζ<sup>dim</sup> %” ratio of CD4+ (black dots) and CD8+ (empty ...
<p>PBMCs (5×10<sup>6</sup>/12 well) were expanded for 12 days using the HAdV peptide pool and IL-15,...
<p>(A) Comparison of the ability of healthy donors and CHB patients to produce IFN-α. PBMCs (2×10<su...
<p>(<b>A, B</b>) Healthy donor PBMCs were treated with different concentrations of EPs 7630 as indic...
<p><b>A</b>. PBMC from Endemic Normal (EN), Microfilaraemic (MF) and Chronic Pathology (CP) groups w...
We evaluated disseminated tumor cells (DTCs) and circulating tumor cells (CTCs) in patients with sta...
<p>Vδ2<sup>+</sup> T cell frequencies in expanded cells (Vδ2<sup>+</sup>CD3<sup>+</sup> staining) an...
<p><b>A, B</b>) Vδ2<sup>+</sup>CD3<sup>+</sup> cell fold increases in LR (n = 16) and R (n = 32) EOC...
<p>(A) PBMC proliferation stimulated by different parental somatic cells (SFs and UMCs). (B) Prolife...
Flow-cytometry analysis of healthy donor and patients PBMC following three days of PMA/ionomycin sti...
<p>Each value represents the mean ± SD of multiple experiments (each point being in triplicate). PBM...
<p>(A) CD100 expression on CD5+ and CD5- B cells from one representative, healthy donor before and a...
B cells were isolated and stimulated with CD40L/LPS/CpG for 2 days. Unstimulated (US) and stimulated...
<p>Bovine PBMCs were labeled with CFSE before stimulation with FTA alone, BVDV alone or BVDV plus FT...
<p>Venous blood samples from 4 healthy donors were stimulated with SEB for 24 hours either as whole ...
<p>Averaged “CD3ζ<sup>bright</sup>/CD3ζ<sup>dim</sup> %” ratio of CD4+ (black dots) and CD8+ (empty ...
<p>PBMCs (5×10<sup>6</sup>/12 well) were expanded for 12 days using the HAdV peptide pool and IL-15,...
<p>(A) Comparison of the ability of healthy donors and CHB patients to produce IFN-α. PBMCs (2×10<su...
<p>(<b>A, B</b>) Healthy donor PBMCs were treated with different concentrations of EPs 7630 as indic...
<p><b>A</b>. PBMC from Endemic Normal (EN), Microfilaraemic (MF) and Chronic Pathology (CP) groups w...
We evaluated disseminated tumor cells (DTCs) and circulating tumor cells (CTCs) in patients with sta...